Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS’ EQUITY (Tables)

v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Apr. 30, 2026
Equity [Abstract]  
SCHEDULE OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS

A summary of the changes in RSUs and DSUs outstanding during the years ended April 30, 2026 and 2025, is as follows:

 

    Restricted and Deferred
Stock Units
    Weighted
Average
Grant-Date
Fair Value
Per Share
 
Balance at April 30, 2024     433,475     $ 10.31  
Granted     160,913       7.62  
Vested and converted into common stock     (7,927 )     9.34  
Balance at April 30, 2025     586,461     $ 9.60  
Granted     84,325       19.24  
Balance at April 30, 2026     670,786     $ 10.81  
SCHEDULE OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity during the years ended April 30, 2026 and 2025:

 

    Number of
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
(Years)
 
Balance at April 30, 2024     192,750     $ 5.54       3.44  
Granted     293,730       7.65       5.00  
Exercised                  
Forfeited     (27,810 )     6.06        
Cancelled                  
Balance at April 30, 2025     458,670     $ 6.86       3.77  
Granted     109,588       19.24       5.00  
Exercised     (17,702 )     6.61       3.42  
Forfeited                  
Cancelled     (2,500 )     7.52       4.79  
Balance at April 30, 2026     548,056     $ 9.34       3.16  
                         
Options exercisable at end of year     406,195     $ 6.80          
Options expected to vest     141,861     $ 16.60          
Weighted average fair value of options granted during the year           $ 10.73          
SCHEDULE OF STOCK OPTION VALUATION ASSUMPTION

The Company used the Black-Scholes model to determine the fair value of stock options granted during the years ended April 30, 2026 and 2025. In applying the Black-Scholes option pricing model to options granted, the Company used the following assumptions:

 

    For the Year
Ended
April 30, 2026
    For the Year
Ended
April 30, 2025
 
Risk-free interest rate     3.83 %     4.17% to 4.43 %
Dividend yield     0.00 %     0.00 %
Expected volatility     62 %     76% to 77 %
Contractual and expected term (in years)     5.0       5.0  
Forfeiture rate     0.00 %     0.00 %
SCHEDULE OF STOCK BASED EXPENSE FOR STOCK OPTION

Stock-based expense for stock options were recorded in the following as reflected in the consolidated statements of operations:

 

    For the Year Ended
April 30, 2026
    For the Year Ended
April 30, 2025
 
Compensation and related taxes – general and administrative   $ 285,244     $ 485,528  
Professional and consulting fees     352,677       605,504  
Total   $ 637,921     $ 1,091,032  
SCHEDULE OF STOCK WARRANT ACTIVITY

The following is a summary of the Company’s stock warrant activity during the years ended April 30, 2026 and 2025:

 

    Number of Warrants     Weighted Average
Exercise
Price
    Weighted Average Remaining Contractual
Life
(Years)
 
                   
Balance at April 30, 2024     4,179,262     $ 6.66       4.01  
Granted     728,850       9.50       10.00  
Exercised     (464,668 )     5.01       3.02  
Forfeited                  
Canceled                  
Balance at April 30, 2025     4,443,444     $ 7.30       2.93  
Granted     961,079       23.00       2.00  
Exercised     (2,238,940 )     6.86       1.64  
Forfeited                  
Canceled                  
Balance at April 30, 2026     3,165,583     $ 12.38       2.05  
Warrants exercisable at end of year     3,165,583     $ 12.38          
Weighted average fair value of warrants granted during the year           $ 23.00